Skip to main content
Premium Trial:

Request an Annual Quote

Akoya Biosciences Closes $50M Funding Round

NEW YORK – Akoya Biosciences said today that it has closed a $50 million funding round.

The Menlo Park, California-based company plans to use the proceeds to fund operation and commercial growth as well as development of its Codex and Phenoptics spatial omics platforms.

The financing was led by Piper Jaffray Merchant Banking and included previous investor Telegraph Hill Partners. New investors included Agilent Technologies and Innovatus Capital Partners. It follows a 2018 Series C round that Akoya used to fund the $37 million acquisition of PerkinElmer's Phenoptics portfolio.

"Akoya is transforming how immunotherapies are developed, from discovery of novel biomarkers in the tumor microenvironment, to deploying high-throughput, highly sensitive information to direct patient therapies." Thomas Schnettler, managing director at Piper Jaffray, said in a statement. "Our investment represents our confidence in Akoya's relentless execution to deliver the next generation of pathology tools."

Schnettler has also joined Akoya's board of directors.

Akoya's platforms allow for multiplexed imaging of protein markers at the single-cell level.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.